Beacon Therapeutics

About Beacon Therapeutics

Beacon Therapeutics is an ophthalmic gene therapy company founded to save and restore the vision of patients with a range of prevalent and rare retinal diseases that result in blindness. Their mission is to transform lives through pioneering ocular gene therapy.

Products & Services

AAV Gene Therapy:A therapy for ophthalmic disorders that involves modifying a patient's cells by adding a functional copy of the mutated gene to treat or prevent genetic conditions, potentially providing long-lasting benefits with a single treatment.

Clinical Trials for Retinal Diseases:Focused on diseases like X-Linked Retinitis Pigmentosa (XLRP), Dry Age-related Macular Degeneration (dAMD), and Cone Rod Dystrophy (CRD), with ongoing trials such as the LANDSCAPE phase 2 trial for XLRP.

Specialties

Ophthalmic Gene Therapy AAV Gene Therapy Retinal Disease Treatment Clinical Trials for Vision Restoration

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series C T: - FT: Series C	A: 75000000 MR: - FA: over $75 million FAN: 75000000	D: 2026-01-08 FD: 2026-01-08	6 investors
2	RT: Series B T: - FT: Series B	A: 170000000 MR: - FA: 170 million FAN: 170000000	D: 2024-07-03 FD: 2024-07-03	6 investors
3	RT: Seed T: - FT: Seed	A: 120000000 MR: - FA: £96 million FAN: 120000000	D: 2023-06-12 FD: 2023-06-12	2 investors
4	RT: Equity Financing T: - FT: Equity Financing	A: 120000000 MR: - FA: £96 million FAN: 120000000	D: 2023-06-12 FD: 2023-06-12	2 investors

Series C Latest

2026-01-08

$75.0M

6 investors (Pro only)

Series B 2024-07-03

$170.0M

Seed 2023-06-12

$120.0M

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

L

Lance Baldo

Chief Executive Officer

D

Daniel Chung

Chief Medical Officer

A

Abraham Scaria

Chief Scientific Officer

T

Thomas Biancardi

Chief Financial Officer

N

Natasha Jarrett

SVP, Regulatory Affairs

B

Brian Mullan

SVP, Technical Operations

View 15 more team members with Pro

Unlock Full Team Directory

Recent News